At 26 weeks, PIONEER 12 was relatively short compared with most of the global PIONEER trials, except for PIONEER 1 and 5, and was considerably shorter than the 78 week PIONEER 3 trial that it mirrors
At the 12 mg dose, systolic blood pressure dropped by 14.0 mmHg, with reductions in non-HDL cholesterol, triglycerides, and high-sensitivity CRP (a marker of inflammation)
T3 correlates with both plasma GLP-1 and fecal FXR-antagonistic bile acid levels in people with normal thyroid function
Barbiero JK, Santiago RM, Persike DS, da Silva Fernandes MJ, Tonin FS, da Cunha C, et al
Two grams of oral or intravenous (IV) glutathione that was used improved their dyspnea within 1 h of use